evidence must be considered as part of any discussion of the risks or benefits of vaccination.
Arthur Zahalsky, Southern Illinois University, Edwardsville Dr. Zahalsky addressed the need for new and improved vaccines against diphtheria and tetanus. He cited the low purity and undesired side effects of the vaccines and maintained that the bovine components of the vaccines are responsible for adverse events, particularly in the adult population. He made suggestions for the further purification of diphtheria and tetanus toxins in the manufacture of vaccines.
In addition to the formal presentations, information on adverse events following vaccination was received from the following sources:
Bell of Atri, Inc., College Park, Maryland. Material from J. Anthony Morris and Hillary Butler on adverse events after hepatitis B vaccination.
Colette Cogliandro, Chesapeake, Virginia. Case report regarding MMR vaccination.
Philippe Duclos, Health and Welfare Canada. Information on adverse events following hepatitis B vaccine.
Reinhard Fescharek, Behringwerke AG, Marburg, Germany. Published literature on diabetes and measles/mumps vaccine.
Bonnie Plumeri Franz, Ogdensburg, New York. Letter regarding concerns about the adequacy and accuracy of research relating to adverse events following receipt of vaccines.
Susan Garzonio, Brodhead, Wisconsin. Case report regarding diphtheriatetanus toxoids.
Cynthia Goldenberg, Laguna Niguel, California. Information on autism and vaccination.
Terry and Kurt Johnson, Mission Viejo, California. Book by Neil Z. Miller, Vaccines: Are They Really Safe and Effective?, New Atlantean Press, Santa Fe, New Mexico, 1992.
Gloria Koslofsky, Norwood, New York. Case report regarding DPT and DT.
Kathleen Lane, Spring City, Pennsylvania. Case report regarding inactivated poliovirus vaccine.
Ruth Macrides, Naples, Florida. Case report regarding hepatitis B vaccine.